• INTETUMUMAB CHEMBL1743032 Antineoplastic

    Alternate Names:

    Intetumumab
    CNTO-095
    CNTO-95

    Drug Info:

    FDA Approval not approved
    Drug Class monoclonal antibody
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Direct Interaction yes
    Mechanism of Interaction Integrin alpha-V/beta-3 antagonist
    Trial Name CNTO-95

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Integrin alpha-V/beta-5 antagonist
    Direct Interaction yes
    Trial Name CNTO-95

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Integrin alpha-V/beta-6 antagonist
    Direct Interaction yes

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Trial Name CNTO-95
    Novel drug target Established target
    Mechanism of Interaction Integrin alpha-V/beta-1 antagonist

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Mechanism of Interaction Integrin alpha-V/beta-1 antagonist
    Direct Interaction yes

    Publications:

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class monoclonal antibody
    FDA Approval not approved

    Publications:

    • Version: chembl_23

    Alternate Names:

    Drug Info:

    Publications: